NCT00518999 Emotional and Cognitive Abilites of Schizophrenia Patients at Various Time Points Status UNKNOWN Phase N/A
NCT00518323 A Double-blind, Placebo-controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent Patients Status COMPLETED Phase PHASE3
NCT00517075 Treatment of Negative Symptoms of Schizophrenia With Transcranial Magnetic Stimulation (TMS) Status TERMINATED Phase PHASE2
NCT00515671 Illness Management and Recovery for Veterans With Severe Mental Illness Status COMPLETED Phase NA
NCT00515489 Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic Patients Status TERMINATED Phase N/A
NCT00514449 Systematic Evaluation of Antiviral Medication in Schizophrenia Status COMPLETED Phase PHASE2
NCT00514423 How Can Rehospitalisations of Patients With Schizophrenia be Avoided? A Comparison Between Different Compliance Programs Status COMPLETED Phase NA
NCT00512070 Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine Status COMPLETED Phase NA
NCT00511628 Study on the Safety of Risperidone on Obese or Overweight Patients With Schizophrenia Status TERMINATED Phase N/A
NCT00511277 Efficacy and Safety of Quetiapine in Treating Affective Symptoms of Patients With First-episode psychosis-a Pilot Study Status COMPLETED Phase PHASE4
NCT00510211 An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients. Status COMPLETED Phase N/A
NCT00509067 Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With Schizophrenia Status COMPLETED Phase PHASE2
NCT00508157 A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome Status TERMINATED Phase PHASE4
NCT00505973 Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese Male Subjects Status COMPLETED Phase PHASE1
NCT00501618 Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder Status COMPLETED Phase PHASE4